Neuralink’s Patient Registry Opens to Canada
Our Patient Registry is now accepting applications from Canadian residents!
By participating in our Patient Registry, you will inform the design and development of our devices so that they better address the medical and assistive technology needs of individuals with various neurological conditions.
This international expansion allows us to assess preliminary eligibility of participants for future Neuralink clinical trials in Canada.
To apply and participate in the Patient Registry you must be at least 18 years old, meet the age of majority in your state or province/territory, and be a U.S. or Canadian resident with any of the following:
- Quadriplegia (paralysis or severe weakness in all four limbs)
- Paraplegia (paralysis in at least two limbs)
- Vision loss
- Hearing loss
- Aphasia (inability to speak)
- Amputee (major limb amputation above or below the elbow and/or above or below the knee)
Your participation in our Patient Registry will not enroll you or guarantee your enrollment in any future Neuralink clinical trial. Moreover, participation in our Patient Registry is not a prerequisite to participate in future Neuralink clinical trials. While we do not currently have any clinical trials available in Canada, our clinical trial for US residents (the PRIME Study) is open to recruitment.
We encourage you to join us on this exciting journey towards innovation and discovery!